Latest News for: Oslo clinic

Edit

Ultimovacs ASA: Annual Report 2023

MENA FN 21 Mar 2024
(MENAFN - GlobeNewsWire - Nasdaq) Oslo, 21 March 2024. Ultimovacs ASA (–Ultimovacs–, ticker ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces that ... .
Edit

First Successful Transplantation of Cryopreserved Ovarian Tissue in Greece Results in Pregnancy

Greek City Times 06 Mar 2024
This procedure, performed by specialists at the Genesis Clinic of Athens in collaboration with a team from Oslo University Hospital, proved successful ... clinical protocols surrounding such procedures.
Edit

Oncoinvent to Present at Evercore ISI 2024 Emerging Biotech Conference

Enid News & Eagle 21 Feb 2024
OSLO, Norway--(BUSINESS WIRE)--Feb 21, 2024-- ... Oncoinvent AS is a clinical stage company developing innovative radiopharmaceutical technology that delivers precise, alpha-emitting particles across solid cancers.
Edit

LumiThera Announces Initiation of EUROLIGHT Registry Study to Evaluate Long-term Benefits of Photobiomodulation (PBM) Treatment ...

The Eagle-Tribune 16 Jan 2024
“We are thrilled to be part of the EUROLIGHT study,” said Oygunn Uthiem, MD, PhD, Norwegian Dry Eye Clinic/Øyehelseklinikken, Department of Medical Biochemistry/Department of Ophthalmology, Oslo University Hospital.
Edit

Therapy to treat rare, hereditary diseases: Study

Hindustan Times 25 Nov 2023
Way to deliver clinically used gene therapy vectors ... He has established a research team at NTNU and Oslo University Hospital that conducts basic research on rare, hereditary diseases with a long-term goal of finding new therapies.
Edit

Newly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen®, Patented Nicotinamide Riboside (NR), ...

Tyler Morning Telegraph 15 Nov 2023
... from a phase II clinical study published in the peer-reviewed journal, Movement Disorders, by a team of researchers led by Dr. Hilde Nilsen, University of Oslo, Arkershus University Hospital, Norway.
Edit

Up Norway: New Nordic Wellness Journey through Scandinavia

TravelDailyNews 10 Nov 2023
OSLO, NORWAY – Up Norway, a leading curator of sustainable luxury travel, is now offering a ... Through a collaboration with the Oslo Sleep Clinic, Up Norway sets up travelers with hands-on sleep therapy.
Edit

Oncoinvent Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for Radspherin® in Ovarian ...

The Joplin Globe 31 Oct 2023
OSLO, Norway--(BUSINESS WIRE)--Oct 31, 2023--. Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced that it has received clearance from the U.S.
Edit

Oncoinvent Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for Radspherin® in Colorectal ...

The Galveston Daily News 27 Oct 2023
OSLO, Norway--(BUSINESS WIRE)--Oct 27, 2023--. Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced that it has received clearance from the U.S.
Edit

NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients ...

The Galveston Daily News 17 Oct 2023
The study which was published in Frontiers in Immunology was performed in collaboration with Oslo University Hospital (OUH) in addition to other collaborators from the SARC028 sarcoma clinical trial, ...
Edit

Remofuscin® prevented retinal thinning in Stargardt disease patients

Pharmiweb 12 Oct 2023
... treat gastro-esophageal reflux disease (GERD), and had completed Phase I and Phase II clinical trials ... Philipp Herrmann Smerud Medical Research, Oslo (clinical research organization) Katairo (sponsor).
Edit

Neoadjuvant study with LTX-315 in early-stage melanoma patients to be presented at the 15th Nordic melanoma meeting

Pharmiweb 10 Oct 2023
Based in Oslo, Norway, Lytix Biopharma is a clinical stage immuno-oncology company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer.
Edit

Oncoinvent Presents Preliminary 18-Month Safety and Efficacy Data from Ongoing RAD-18-002 Phase 1/2A Trial of ...

The Galveston Daily News 04 Oct 2023
OSLO, Norway--(BUSINESS WIRE)--Oct 4, 2023-- ... “These data represent a significant clinical milestone for Radspherin®, giving us confidence in its potential to prevent peritoneal recurrence.
Edit

Oncoinvent To Present Initial Safety Data from the Phase 1 Trial of Radspherin® in Ovarian ...

The Eagle-Tribune 28 Sep 2023
OSLO, Norway--(BUSINESS WIRE)--Sep 28, 2023-- ... Oncoinvent AS is a clinical stage company developing innovative radiopharmaceutical technology that delivers precise, alpha-emitting particles across solid cancers.
Edit

Lytix Biopharma announces completion of patient recruitment in the ATLAS-IT-05 trial

Pharmiweb 29 Aug 2023
Oslo, 29 August 2023. Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo. LYTIX), a clinical stage immuno-oncology company, announces that it has completed recruitment of 20 patients ...
×